Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma

Annals of Surgical Oncology

Volumn 13, Issue 12, 2006, Pages 1569-1578

  Shimada, Kazuaki ^a   Sano, Tsuyoshi ^a   Sakamoto, Yoshihiro ^a   Kosuge, Tomoo ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Pancreatic cancer; Portal vein resection; Postoperative complications; Predictive factors; Recurrence pattern

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; APPLICATION SITE BLEEDING; ARTICLE; ASCITES; BILE DUCT FISTULA; CANCER INFILTRATION; CANCER INVASION; CANCER SURVIVAL; CHOLANGITIS; CONTROLLED STUDY; FALSE ANEURYSM; FEMALE; HUMAN; INCIDENCE; INTESTINE FISTULA; LIVER ABSCESS; LIVER DYSFUNCTION; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NERVE PLEXUS; PALLIATIVE THERAPY; PANCREAS CARCINOMA; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PATHOLOGY; PERIOPERATIVE PERIOD; PORTAL VEIN; POSTOPERATIVE HEMORRHAGE; RECURRENCE RISK; REOPERATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; STOMACH EMPTYING; STOMACH ULCER; SURGICAL MORTALITY; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33845631984     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9143-4     Document Type: Article

References (29)

1. Warshaw AL, Castillo CF. Pancreatic carcinoma. N Engl J Med 1992; 326:455-465.
2. Nitecki SS, Sarr MG, Colby TV, Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving?. Ann Surg 1995; 221:59-66.
3. Ishikawa O, Ohigashi H, Imaoka S, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992; 215:231-236.
4. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994; 167:104-113.
5. Furukawa H, Kosuge T, Mukai K, et al. Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma. Arch Surg 1998; 133:61-65.
6. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 1994; 81:1190-1193.
7. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery 1995; 117:50-55.
8. Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection?. Ann Surg 1996; 224:342-349.
9. Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998; 85:611-617.
10. Bachellier P, Nakano H, Oussoultzoglou E, et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?. Am J Surg 2001; 182:120-129.
11. Hartel M, Niedergethmann M, Farag-Soliman M, et al. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002; 168:707-12.
12. Nakaghori T, Kinoshita T, Konishi M, et al. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 2003; 186:149-153.
13. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg 1996; 223:154-162.
14. Tseng JF, Raut CP, Lee JE, et al. Pancreatoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004; 8:935-49.
15. Roder JD, Stein HJ, Siewert JR. Carcinoma of the periampullary region: who benefits from portal vein resection?. Am J Surg 1996; 171:170-175.
16. Launois B, Stasik C, Bardaxoglou E, et al. Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?. World J Surg 1999; 23:926-929.
17. Geenen RC, Kate FJ, Wit LT, et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 2001; 129:158-163.
18. Yachida S, Fukushima N, Sakamoto M, Matsuno T, Kosuge T, Hirohashi S. Implications of peritoneal washing cytology in patients with potentially respectable pancreatic cancer. Br J Surg 2002; 89:573-578.
19. Ozaki H, Kinoshita H, Kosuge T, et al. Long-term survival after multimodality treatment for resectable pancreatic cancer. Int J Pancteatol 2000; 27:217-224.
20. Shimada K, Sano T, Sakamoto Y, Kosuge T. Safe management of the pancreatic remnant with prolamine duct occlusion after extended pancreaticoduodenectomy. Hepatogastroenterology 2005; 52:1872-7.
21. st Engl edn Tokyo: Kanehara; 1996.
22. Sobin LH, Wittekind Ch. TNM Classification of Malignant tumors6 New York, NY: JohnWiley 2002.
23. Hamanaka Y, Nishihama K, Hamasaki T, et al. Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery 1996; 119:281-287.
24. Ishikawa O, Ohhigashi H, Sasaki Y, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988; 208:215-220.
25. Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 1998; 433:237-242.
26. Nagai H, Koroda A, Morioka Y. Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg 1986; 204:65-71.
27. Ishikawa O, Ohigashi H, Sasaki Y, et al. Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreaticoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg 1998; 175:477-481.
28. Nakao A, Kaneko T. Intravascular ultrasonography for assessment of portal vein invasion by pancreatic carcinoma. World J Surg 1999; 23:892-5.
29. Yamaue H, Tani M, Onishi H, et al. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection. Pancreas 2002; 25:366-372.